A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder
NCT06710431
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Alcohol Abuse
Alcohol Abuse/addiction
Anxiety
Pain Threshold
Depression Disorders
Sleep Disorder
Interventions
DRUG:
AFA-281
Sponsor
Afasci Inc